Exposure to temozolomide (TMZ) increases the expression of KLF4 and reduces the expression of Nanog and OCT4 in glioma cells [16], indicating that stem cell factors, especially KLF4, play pivotal roles in GSCs. This evidence concerns the gene KLF4 and glioma.